In last trading session, Outset Medical Inc (NASDAQ:OM) saw 0.32 million shares changing hands with its beta currently measuring 2.15. Company’s recent per share price level of $17.42 trading at -$0.18 or -1.02% at ring of the bell on the day assigns it a market valuation of $308.36M. That closing price of OM’s stock is at a discount of -291.39% from its 52-week high price of $68.18 and is indicating a premium of 66.42% from its 52-week low price of $5.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.25 million shares which gives us an average trading volume of 334.98K if we extend that period to 3-months.
For Outset Medical Inc (OM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.80. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.98 in the current quarter.
Outset Medical Inc (NASDAQ:OM) trade information
Outset Medical Inc’s shares saw a change of -75.91% in year-to-date performance and have moved -10.16% in past 5-day. Outset Medical Inc (NASDAQ:OM) showed a performance of -8.03% in past 30-days. Number of shares sold short was 1.01 million shares which calculate 3.54 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 26 to the stock, which implies a rise of 33.0% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 37. It follows that stock’s current price would jump 13.89% in reaching the projected high whereas dropping to the targeted low would mean a gain of 13.89% for stock’s current value.
Outset Medical Inc (OM) estimates and forecasts
This year revenue growth is estimated to rise 7.32% from the last financial year’s standing. 5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 29.4M for the same. And 5 analysts are in estimates of company making revenue of 30.52M in the next quarter. Company posted 27.39M and 28.67M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -4.06% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 80.74% while estimates for its earnings growth in next 5 years are of 48.44%.
Outset Medical Inc (NASDAQ:OM)’s Major holders
Insiders are in possession of 2.69% of company’s total shares while institution are holding 83.27 percent of that, with stock having share float percentage of 85.57%. Investors also watch the number of corporate investors in a company very closely, which is 83.27% institutions for Outset Medical Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at OM for having 7.7 million shares of worth $29.63 million. And as of 2024-06-30, it was holding 0.9891 of the company’s outstanding shares.
The second largest institutional holder is AMERIPRISE FINANCIAL INC, which was holding about 5.2 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.6682 of outstanding shares, having a total worth of $20.02 million.
On the other hand, Fidelity Select Portfolios-Health Care Portfolio and Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 1.33 shares of worth $23.26 million or 7.53% of the total outstanding shares. The later fund manager was in possession of 800.0 shares on May 31, 2025 , making its stake of worth around $13.94 million in the company or a holder of 4.51% of company’s stock.
